Differentially Expressed Circulating microRNAs in the Development of Acute Diabetic Charcot Foot

References

• Abi Khalil C , RousselR , MohammediK , DanchinN , MarreM . Cause-specific mortality in diabetes: recent changes in trend mortality . Eur. J. Prev. Cardiol.19 ( 3 ), 374 – 381 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Huang D , RefaatM , MohammediK , JayyousiA , Al SuwaidiJ , Abi KhalilC . Macrovascular complications in patients with diabetes and prediabetes . Biomed. Res. Int.2017 , 7839101 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Pop-Busui R , BoultonAJ , FeldmanELet al. Diabetic neuropathy: a position statement by the American Diabetes Association . Diabetes Care40 ( 1 ), 136 – 154 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Nobrega MB , ArasR , NettoEMet al. Risk factors for Charcot foot . Arch. Endocrinol. Metab.59 ( 3 ), 226 – 230 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Tuttolomondo A , MaidaC , PintoA . Diabetic foot syndrome as a possible cardiovascular marker in diabetic patients . J. Diabetes Res.2015 , 268390 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Young MJ , MarshallA , AdamsJE , SelbyPL , BoultonAJ . Osteopenia, neurological dysfunction, and the development of Charcot neuroarthropathy . Diabetes Care18 ( 1 ), 34 – 38 ( 1995 ).
   PubMed Web of Science ®Google Scholar
• Tuttolomondo A , MaidaC , PintoA . Diabetic foot syndrome: Immune-inflammatory features as possible cardiovascular markers in diabetes . World J. Orthop.6 ( 1 ), 62 – 76 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Mabilleau G , PetrovaN , EdmondsME , SabokbarA . Number of circulating CD14-positive cells and the serum levels of TNF-α are raised in acute Charcot foot . Diabetes Care34 ( 3 ), e33 ( 2011 ).
   PubMedGoogle Scholar
• Pasquier J , ThomasB , Hoarau-VechotJet al. Circulating microparticles in acute diabetic Charcot foot exhibit a high content of inflammatory cytokines, and support monocyte-to-osteoclast cell induction . Sci. Rep.7 ( 1 ), 16450 ( 2017 ).
   PubMedGoogle Scholar
• Petrova NL , EdmondsME . Acute Charcot neuro-osteoarthropathy . Diabetes Metab. Res. Rev.32 ( Suppl. 1 ), 281 – 286 ( 2016 ).
   PubMedGoogle Scholar
• Uccioli L , SinistroA , AlmerighiCet al. Proinflammatory modulation of the surface and cytokine phenotype of monocytes in patients with acute Charcot foot . Diabetes Care33 ( 2 ), 350 – 355 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Mabilleau G , PetrovaNL , EdmondsME , SabokbarA . Increased osteoclastic activity in acute Charcot’s osteoarthropathy: the role of receptor activator of nuclear factor-κB ligand . Diabetologia51 ( 6 ), 1035 – 1040 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Bartel DP . miRNAs: genomics, biogenesis, mechanism, and function . Cell116 ( 2 ), 281 – 297 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Arroyo JD , ChevilletJR , KrohEMet al. Argonaute2 complexes carry a population of circulating miRNAs independent of vesicles in human plasma . Proc. Natl Acad. Sci. USA108 ( 12 ), 5003 – 5008 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Chen X , BaY , MaLet al. Characterization of miRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases . Cell Res.18 ( 10 ), 997 – 1006 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Weber JA , BaxterDH , ZhangSet al. The miRNA spectrum in 12 body fluids . Clin. Chem.56 ( 11 ), 1733 – 1741 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Da Silveira JC , VeeramachaneniDN , WingerQA , CarnevaleEM , BoumaGJ . Cell-secreted vesicles in equine ovarian follicular fluid contain miRNAs and proteins: a possible new form of cell communication within the ovarian follicle . Biol. Reprod.86 ( 3 ), 71 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Thomas MR , LipGY . Novel risk markers and risk assessments for cardiovascular disease . Circ. Res.120 ( 1 ), 133 – 149 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Bayraktar R , Van RoosbroeckK , CalinGA . Cell-to-cell communication: miRNAs as hormones . Mol. Oncol.11 ( 12 ), 1673 – 1686 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Borujeni MJS , EsfandiaryE , TaheripakG , Codoner-FranchP , Alonso-IglesiasE , MirzaeiH . Molecular aspects of diabetes mellitus: resistin, miRNA and exosome . J. Cell Biochem.119 ( 2 ), 1257 – 1272 ( 2018 ).
   PubMed Web of Science ®Google Scholar
• Pasquier J , Hoarau-VechotJ , FakhroK , RafiiA , Abi KhalilC . Epigenetics and cardiovascular disease in diabetes . Curr. Diab. Rep.15 ( 12 ), 108 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Rogers LC , FrykbergRG , ArmstrongDGet al. The Charcot foot in diabetes . Diabetes Care34 ( 9 ), 2123 – 2129 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Sun Y , PengR , PengHet al. miR-451 suppresses the NF-κB-mediated proinflammatory molecules expression through inhibiting LMP7 in diabetic nephropathy . Mol. Cell Endocrinol.433 , 75 – 86 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Kocijan R , MuschitzC , GeigerEet al. Circulating miRNA signatures in patients with idiopathic and postmenopausal osteoporosis and fragility fractures . J. Clin. Endocrinol. Metab.101 ( 11 ), 4125 – 4134 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Kim BS , JungJY , JeonJY , KimHA , SuhCH . Circulating hsa-miR-30e-5p, hsa-miR-92a-3p, and hsa-miR-223-3p may be novel biomarkers in systemic lupus erythematosus . HLA88 ( 4 ), 187 – 193 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Madhavan D , PengC , WallwienerMet al. Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis . Carcinogenesis37 ( 5 ), 461 – 470 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Khan FH , PandianV , RamrajS , AravindanS , HermanTS , AravindanN . Reorganization of metastamiRs in the evolution of metastatic aggressive neuroblastoma cells . BMC Genomics16 , 501 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Yan H , WangS , YuH , ZhuJ , ChenC . Molecular pathways and functional analysis of miRNA expression associated with paclitaxel-induced apoptosis in hepatocellular carcinoma cells . Pharmacology92 ( 3–4 ), 167 – 174 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Zou M , WangF , GaoRet al. Autophagy inhibition of hsa-miR-19a-3p/19b-3p by targeting TGF-β R II during TGF-β1-induced fibrogenesis in human cardiac fibroblasts . Sci. Rep.6 , 24747 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Tang Y , ZhangYC , ChenY , XiangY , ShenCX , LiYG . The role of miR-19b in the inhibition of endothelial cell apoptosis and its relationship with coronary artery disease . Sci. Rep.5 , 15132 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Calimlioglu B , KaragozK , SevimogluT , KilicE , GovE , ArgaKY . Tissue-specific molecular biomarker signatures of Type 2 diabetes: an integrative analysis of transcriptomics and protein–protein interaction data . OMICS19 ( 9 ), 563 – 573 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Liu D , LiYW , LuoGet al. LncRNA SPRY4-IT1 sponges miR-101-3p to promote proliferation and metastasis of bladder cancer cells through up-regulating EZH2* . Cancer Lett.388 , 281 – 291 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Chang L , YuanYF , LiCCet al. Upregulation of SNHG6 regulates ZEB1 expression by competitively binding miR-101-3p and interacting with UPF1 in hepatocellular carcinoma . Cancer Letters383 ( 2 ), 183 – 194 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Sun YX , ZhangJF , XuJet al. miRNA-144-3p inhibits bone formation in distraction osteogenesis through targeting Connexin 43 . Oncotarget8 ( 52 ), 89913 – 89922 ( 2017 ).
   PubMedGoogle Scholar
• Song J , KangYH , YoonS , ChunCH , JinEJ . HIF-1a: CRAT: miR-144-3p axis dysregulation promotes osteoarthritis chondrocyte apoptosis and VLCFA accumulation . Oncotarget8 ( 41 ), 69351 – 69361 ( 2017 ).
   PubMedGoogle Scholar
• Wang Y , ZhangYY , YangTet al. Long non-coding RNA MALAT1 for promoting metastasis and proliferation by acting as a ceRNA of miR-144-3p in osteosarcoma cells . Oncotarget8 ( 35 ), 59417 – 59434 ( 2017 ).
   PubMedGoogle Scholar
• Shen HX , LiWJ , TianYet al. Upregulation of miR-362-3p Modulates proliferation and anchorage-independent growth by directly targeting Tob2 in hepatocellular carcinoma . J. Cell. Biochem.116 ( 8 ), 1563 – 1573 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Christensen LL , TobiasenH , HolmAet al. miRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer . Int. J. Cancer133 ( 1 ), 67 – 78 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Wang K , YuanY , ChoJH , McClartyS , BaxterD , GalasDJ . Comparing the miRNA spectrum between serum and plasma . PLoS One7 ( 7 ), e41561 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Wang K , ZhangS , WeberJ , BaxterD , GalasDJ . Export of miRNAs and miRNA-protective protein by mammalian cells . Nucliec Acids Res.38 ( 20 ), 7248 – 7259 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Mestdagh P , HartmannN , BaeriswylLet al. Evaluation of quantitative miRNA expression platforms in the miRNA quality control (miRQC) study . Nat. Methods11 ( 8 ), 809 – 815 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Li Q , ChenL , ChenD , WuX , ChenM . Influence of miRNA-related polymorphisms on clinical outcomes in coronary artery disease . Am. J. Transl. Res.7 ( 2 ), 393 – 400 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Neal CS , MichaelMZ , PimlottLK , YongTY , LiJY , GleadleJM . Circulating miRNA expression is reduced in chronic kidney disease . Nephrol. Dial. Transplant.26 ( 11 ), 3794 – 3802 ( 2011 ).
   PubMed Web of Science ®Google Scholar